Global Egg Allergy Market Research Report Forecast to 2023

$4,450$6,250

Clear

Description

Introduction
Eggs are the most common allergy-causing agents, especially in children. Symptoms of egg allergy can occur immediately or within few minutes or few hours. Egg allergy can affect infants as well as adults. The adverse effects of egg allergy can vary from hives or rashes to a severe allergic reaction known as anaphylaxis. Egg allergy happens when there is an overreaction to eggs by the immune system. The immune system identifies egg proteins as harmful and triggers an allergic reaction.
The global egg allergy market is expected to reach a market value of USD 2,304.3 million by 2023 from USD 1,635.3 million in 2018, growing at a CAGR of 7.10% during the forecast period. In 2018, the Americas held the highest share of the market, i.e., 39.7%, followed by Europe and Asia-Pacific with 26.6% and 24.5% market shares respectively.
The global egg allergy market has been segmented on the basis of age group, diagnosis & treatment, end user, and region.
The global egg allergy market, by age group, has been segmented into children and adults.
The global egg allergy market, by diagnosis has been further segmented into skin test, blood test and food challenge. The treatment segment has been further segmented into medication and oral immunotherapy.
The global egg allergy market, by end user, has been segmented into hospitals & clinics, diagnostic centres, and research institute.
The global egg allergy market is expected to reach USD 2,304.3 million by 2023 from USD 1,635.3 million in 2018; it is expected to register a CAGR of 7.10% during the forecast period from 2018 to 2023.
Key Players
Sanofi S.A., Genentech, Inc., Quest Diagnostics, ImmuneTech, HYCOR Biomedical, Kaleo, Inc., Alletess Medical Laboratory, Creative Diagnostics, Imutest Ltd, Mylan N. V., and Impax Laboratories.

Study objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the egg allergy market
• To provide insights into factors affecting the market growth
• To analyze the global egg allergy market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to the current market size and future perspective
• To provide country-level analysis of the market for segments by age group, diagnosis & treatment, end user, and region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the egg allergy market
Target Audience
• Hospitals
• Association
• Egg Allergy Products Manufacturing Companies
Key Findings
• The global egg allergy market is expected to reach USD 2,304.3 million by 2023 at a CAGR of 7.10% from 2017 to 2023
• On the basis of age group, children accounted for the largest market share at a CAGR of 7.34% by 2023
• On the basis of diagnosis & treatment, diagnosis accounted for the largest market share at a CAGR of 7.37% by 2023
• On the basis of end-user, hospitals & clinics accounted for the largest market share at a CAGR of 6.81% by 2023
• The Americas is expected to hold the largest share of the global egg allergy market at a CAGR of 6.46% by 2023
• Asia-Pacific is the fastest growing market, which is expected to grow at a CAGR of 8.71% by 2023
Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Western Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Western Europe
o Eastern Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• The Middle East & Africa
o Middle East
o Africa

Table of Contents

Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions & Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Increasing prevalence of egg allergy
5.2.2 Improved allergy diagnosis
5.3 Restraints
5.3.1 Lack of awareness in developing countries
5.3.2 High Cost
5.4 Opportunity
5.4.1 Technological Advancements in screening
5.5 Challenges
5.5.1 Technical difficulties during testing
6 Market Factor Analysis
6.1 Value Chain Analysis
6.2 R&D
6.3 Product Development
6.4 Manufacturing
6.5 Marketing and Distribution
6.6 Porter’s Five Forces Analysis
6.6.1 Bargaining Power of Suppliers
6.6.2 Bargaining Power of Buyers
6.6.3 Threat of New Entrants
6.6.4 Threat of Substitutes
6.6.5 Intensity of Rivalry
6.7 Investment Opportunities
6.8 Demand & Supply: Gap Analysis
6.9 Price Analysis
7 Global Egg Allergy Market, By Age group
7.1 Introduction
7.1.1 Children (0-18 years)
7.1.2 Adults (18 + years)
8 Global Egg Allergy Market, By Diagnosis & Treatment
8.1 Introduction
8.1.1 Diagnosis
8.1.1.1 Skin Test
8.1.1.2 Blood Test
8.1.1.3 Food Challenge
8.1.2 Treatment
8.1.2.1 Medication
8.1.2.2 Oral immunotherapy
9 Global Egg Allergy Market, By End User
9.1 Introduction
9.1.1 Hospitals & Clinics
9.1.2 Diagnostic Centres
9.1.3 Research institute
10 Global Egg Allergy Market, By Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 France
10.3.1.2 Germany
10.3.1.3 Italy
10.3.1.4 U.K
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East and Africa
10.5.1 Middle east
10.5.2 Africa
11 Competitive Landscape
11.1 Company Market Share Analysis
11.1.1 Introduction
12 Company Profiles
12.1 Sanofi S.A.
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products Offering
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategy
12.2 Genentech, Inc.
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offering
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategy
12.3 Quest Diagnostics
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products Offering
12.3.4 Key Development
12.3.5 SWOT Analysis
12.3.6 Key Strategy
12.4 ImmuneTech
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products Offering
12.4.4 Key Development
12.4.5 SWOT Analysis
12.4.6 Key Strategy
12.5 HYCOR Biomedical
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offering
12.5.4 Key Development
12.5.5 SWOT Analysis
12.5.6 Key Strategy
12.6 Kaleo, Inc.
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offering
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategy
12.7 Alletess Medical Laboratory
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products Offering
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategy
12.8 Creative Diagnostics
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offering
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategy
12.9 Imutest Ltd
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offering
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategy
12.1 Mylan N. V.
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offering
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategy
12.11 Impax Laboratories
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products Offering
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.11.6 Key Strategy
13 Appendix
13.1 Discussion Blue Print

Additional information

Publisher

Geography Covered

Date Published

Pages

Format